Impact of Thymectomy on Immunity in Infants After Cardiac Surgery
Recruiting
N/A
Interventional Study
Congenital Heart Defects
Thymectomy
Immunological Deficiency Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- Up to 6 Months
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 70 (estimated)
- Sponsor
- Nantes University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Heart surgery in infants typically involves complete removal of the thymus gland to improve access to the heart. However, the thymus plays a key role in developing the immune system in early childhood, especially in the production and maturation of T lymphocytes, which help the body defend itself against infections.
The THYMIC study tests the hypothesis that partial removal of the thymus (partial…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* \- Children aged between 0 and 6 months;
* Born at a gestational age \> 37 weeks' gestation;
* With an indication for cardiac surgery under CEC at Nantes University Hospital;
* Cardiopediatric follow-up planned at Nantes University Hospital;
* Written agreement signed by legal…
Contacts